Clincosm LogoSign in Get a demo

plasma cell myeloma

Showing 51 - 75 of 85
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Aplastic Anemia Trial in Philadelphia (procedure, drug, radiation)

Recruiting
  • Acute Lymphoblastic Leukemia
  • +15 more
  • Hematopoietic Cell Transplantation
  • +7 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Apr 1, 2022

People With Multiple Myeloma in MRD-Negative Remission

Recruiting
  • Plasma Cell Myeloma
  • Cessation of continuous matinenace therapy
  • Basking Ridge, New Jersey
  • +6 more
Mar 30, 2022

Plasma Cell Myeloma Trial in Duarte (Best Practice, Exercise Intervention, Quality-of-Life Assessment)

Recruiting
  • Plasma Cell Myeloma
  • Best Practice
  • +3 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 3, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Ixazomib Citrate
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Mar 8, 2022

Survivors of Transplant, CREST Study

Recruiting
  • Acute Lymphoblastic Leukemia
  • +6 more
  • Bioelectric Impedance Analysis
  • +7 more
  • Duarte, California
    City of Hope Comprehensive Cancer Center
Mar 7, 2022

Lymphoma, Malignant Solid Tumor, Plasma Cell Myeloma Trial in Portland (Xisomab 3G3)

Recruiting
  • Lymphoma
  • +2 more
  • Xisomab 3G3
  • Portland, Oregon
    OHSU Knight Cancer Institute
Feb 28, 2022

Bone Pain, Metastatic Malignant Tumor in the Bone, Plasma Cell Myeloma Trial in United States (Quality-of-Life Assessment,

Recruiting
  • Bone Pain
  • +2 more
  • Quality-of-Life Assessment
  • +2 more
  • Duarte, California
  • +7 more
Feb 25, 2022

Breast Tumor, Colorectal Tumor, Female Reproductive System Tumor Trial in Houston (Best Practice, Educational Intervention,

Active, not recruiting
  • Breast Neoplasm
  • +5 more
  • Best Practice
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 25, 2022

Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)

Active, not recruiting
  • Hematopoietic Cell Transplantation Recipient
  • Plasma Cell Myeloma
  • Elotuzumab
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Myeloma Multiple, Myeloma, Plasma-Cell, Myeloma-Multiple Trial in Israel (Carfilzomib, Daratumumab, Lenalidomide)

Completed
  • Myeloma Multiple
  • +3 more
  • Afula, Israel
  • +13 more
Jan 26, 2022

Multiple Myeloma, Myeloma Multiple, Kahler Disease Trial in United States (Selinexor, Dexamethasone Oral, Daratumumab)

Recruiting
  • Multiple Myeloma
  • +6 more
  • Tucson, Arizona
  • +9 more
Jan 5, 2022

Plasma Cell Myeloma Trial in Puerto Rico, United States (Bortezomib, Carfilzomib, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Anchorage, Alaska
  • +919 more
Dec 29, 2021

Plasma Cell Myeloma, Secondary Amyloidosis Trial in Duarte, Nashville (procedure, biological, other, drug)

Recruiting
  • Plasma Cell Myeloma
  • Secondary Amyloidosis
  • Autologous Hematopoietic Stem Cell Transplantation
  • +3 more
  • Duarte, California
  • +1 more
Dec 27, 2021

Plasma Cell Myeloma Trial in Buffalo (Best Practice, Kefir, Quality-of-Life Assessment)

Completed
  • Plasma Cell Myeloma
  • Best Practice
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Nov 15, 2021

COVID-19 Infection, Hematopoietic and Lymphoid System Tumor, Leukemia Trial in Duarte (COVID-19 Vaccine, Diagnostic Laboratory

Recruiting
  • COVID-19 Infection
  • +4 more
  • COVID-19 Vaccine
  • +2 more
  • Duarte, California
    City of Hope Medical Center
Nov 2, 2021

Plasma Cell Myeloma, Residual Disease Trial in Chicago (Ixazomib Citrate, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Plasma Cell Myeloma
  • Residual Disease
  • Ixazomib Citrate
  • +2 more
  • Chicago, Illinois
    University of Chicago
Oct 5, 2021

Plasma Cell Myeloma Trial in Atlanta (Carfilzomib, Dexamethasone, Pomalidomide)

Recruiting
  • Plasma Cell Myeloma
  • Atlanta, Georgia
    Emory University Hospital/Winship Cancer Institute
Oct 5, 2021

Plasma Cell Myeloma Trial in United States (Lenalidomide)

Active, not recruiting
  • Plasma Cell Myeloma
  • Basking Ridge, New Jersey
  • +5 more
Sep 1, 2021

After Whole Brain Radiation Therapy for Hematologic Malignancies

Recruiting
  • Central Nervous System Lymphoma
  • +5 more
  • Magnetic Resonance Imaging
  • +3 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 12, 2021

B-Cell Non-Hodgkin Lymphoma, Hematopoietic and Lymphoid Cell Tumor, Leukemia Trial in Houston (Ipilimumab, Lenalidomide)

Active, not recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +5 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 6, 2021

Plasma Cell Myeloma Trial in United States (Isatuximab SAR650984, Pomalidomide, Dexamethasone)

Completed
  • Plasma Cell Myeloma
  • Isatuximab SAR650984
  • +2 more
  • Scottsdale, Arizona
  • +12 more
Jul 8, 2021

Bone Sarcoma, Femur Fracture, Lymphoma Trial in Houston (Dalteparin)

Completed
Has Results
  • Bone Sarcoma
  • +6 more
  • Houston, Texas
    M D Anderson Cancer Center
Dec 31, 2020

Plasma Cell Myeloma Trial in Houston (procedure, biological, drug)

Recruiting
  • Plasma Cell Myeloma
  • Autologous Hematopoietic Stem Cell Transplantation
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Nov 23, 2020

Indolent Plasma Cell Myeloma, Plasma Cell Myeloma, Smoldering Plasma Cell Myeloma Trial in Rochester (biological, drug, other)

Completed
Has Results
  • Indolent Plasma Cell Myeloma
  • +2 more
  • Anakinra
  • +4 more
  • Rochester, Minnesota
    Mayo Clinic
Mar 13, 2020

Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Lymphocytic Leukemia Trial in Salt Lake City, Seattle, Torino

Completed
Has Results
  • Acute Lymphoblastic Leukemia
  • +9 more
  • Salt Lake City, Utah
  • +4 more
Jan 15, 2020